Hebei Ruishen Pharmaceutical

Hebei Ruishen Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of high-end active pharmaceutical ingredients (APIs) and finished chemical drug products. As a core subsidiary of Hebei Changshan Biochemical Pharmaceutical, the company operates advanced manufacturing facilities in Shijiazhuang that comply with international GMP standards. Its commercial portfolio is notably strong in the men's health sector, featuring products such as dapoxetine hydrochloride and vardenafil hydrochloride. Beyond its own product line, Ruishen provides critical chemical synthesis and API manufacturing support for its parent group's heparin-based therapies. The company serves both the domestic Chinese market and international partners through contract manufacturing and API supply. Its strategic focus remains on high-barrier chemical drugs and the expansion of its global manufacturing footprint.